The market for 1-(3-Amino-2-hydroxyphenyl)ethanone (CAS 70977-72-9) is closely tied to the pharmaceutical industry, particularly the demand for drugs like ranlukast. As a critical intermediate in the synthesis of this and potentially other therapeutic compounds, its market dynamics are influenced by global health trends, regulatory approvals, and advancements in medicinal chemistry.

The primary driver for the demand of 1-(3-Amino-2-hydroxyphenyl)ethanone is the pharmaceutical sector's need for reliable API synthesis. Growth in the treatment of respiratory conditions like asthma directly translates into increased demand for ranlukast, thereby boosting the requirement for its key intermediates. Furthermore, ongoing research and development in drug discovery may uncover new applications for this versatile compound, potentially expanding its market reach.

Pricing for 1-(3-Amino-2-hydroxyphenyl)ethanone is influenced by several factors, including the cost of raw materials, the complexity of the synthesis process, purity requirements, order volume, and the overall supply-demand balance in the chemical market. Manufacturers in China, such as NINGBO INNO PHARMCHEM CO.,LTD., often play a significant role in shaping the global price by offering competitive manufacturing solutions.

When considering procurement, understanding the market landscape allows companies to make strategic purchasing decisions. Identifying key suppliers, comparing price quotes, and ensuring a stable supply chain are essential steps. The availability of high-purity grades (e.g., ≥99.0%) is a crucial differentiator for suppliers. By carefully evaluating market trends and partnering with trusted manufacturers, businesses can secure a consistent and cost-effective supply of this important chemical intermediate, supporting their production and innovation efforts.